HAL (France)open access
Current landscape and future directions of targeted-alpha-therapy for glioblastoma treatment
Actinium-225, Bismuth-213, Targeted-alpha-therapy, 0, Astatine-211, Glioblastoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 315097
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.